CA Stock MarketDetailed Quotes

ONC Oncolytics Biotech Inc

Watchlist
  • 1.550
  • +0.060+4.03%
15min DelayMarket Closed Nov 12 16:00 ET
119.13MMarket Cap-4078P/E (TTM)

Oncolytics Biotech Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
10.61%7.92M
29.58%8.73M
25.51%33.79M
4.01%8.85M
82.31%11.05M
18.43%7.16M
6.72%6.73M
2.63%26.92M
14.13%8.51M
-1.54%6.06M
Selling and administrative expenses
-2.80%3.36M
-6.64%2.98M
41.25%15.68M
14.49%4.08M
124.68%5.13M
26.06%3.46M
22.79%3.2M
-13.71%11.1M
7.32%3.57M
-20.56%2.29M
-General and administrative expense
-2.80%3.36M
-6.64%2.98M
41.25%15.68M
14.49%4.08M
124.68%5.13M
26.06%3.46M
22.79%3.2M
-13.71%11.1M
7.32%3.57M
-20.56%2.29M
Research and development costs
23.16%4.56M
62.28%5.74M
14.76%17.71M
-3.80%4.66M
57.99%5.81M
15.51%3.7M
-4.56%3.54M
19.44%15.43M
31.61%4.84M
12.18%3.68M
Depreciation amortization depletion
----
----
2.81%403K
8.08%107K
6.19%103K
----
----
-13.27%392K
--99K
--97K
-Depreciation and amortization
----
----
2.81%403K
8.08%107K
6.19%103K
----
----
-13.27%392K
--99K
--97K
Operating profit
-10.61%-7.92M
-29.58%-8.73M
-25.51%-33.79M
-4.01%-8.85M
-82.31%-11.05M
-18.43%-7.16M
-6.72%-6.73M
-2.63%-26.92M
-14.13%-8.51M
1.54%-6.06M
Net non-operating interest income (expenses)
27.34%340K
68.30%446K
151.14%1.33M
55.73%489K
108.90%305K
444.90%267K
1,372.22%265K
433.33%528K
1,292.89%314K
467.21%146K
Non-operating interest income
27.34%340K
68.30%446K
151.14%1.33M
55.73%489K
108.90%305K
444.90%267K
1,372.22%265K
433.33%528K
1,292.89%314K
467.21%146K
Other net income (expenses)
183.63%419K
4,231.25%1.39M
192.40%4.81M
1,569.97%4.45M
-45.29%825K
-154.05%-501K
106.57%32K
1,482.35%1.65M
-9.48%-303K
19.28%1.51M
Gain on sale of security
183.63%419K
4,231.25%1.39M
192.40%4.81M
1,569.97%4.45M
-45.29%825K
-154.05%-501K
106.57%32K
1,482.35%1.65M
-9.48%-303K
19.28%1.51M
Income before tax
3.15%-7.16M
-7.10%-6.89M
-11.73%-27.66M
54.03%-3.91M
-125.10%-9.92M
-45.84%-7.39M
5.04%-6.44M
5.73%-24.75M
-10.22%-8.5M
9.43%-4.41M
Income tax
102.13%95K
15.48%97K
-24.56%43K
250.00%7K
88.00%47K
71.43%84K
36.20%57K
-72.03%2K
Earnings from equity interest net of tax
Net income
2.49%-7.26M
-7.10%-6.89M
-11.75%-27.75M
53.83%-3.95M
-125.16%-9.93M
-46.05%-7.44M
5.04%-6.44M
5.58%-24.84M
-10.36%-8.55M
9.53%-4.41M
Net income continuous operations
2.49%-7.26M
-7.10%-6.89M
-11.75%-27.75M
53.83%-3.95M
-125.16%-9.93M
-46.05%-7.44M
5.04%-6.44M
5.58%-24.84M
-10.36%-8.55M
9.53%-4.41M
Noncontrolling interests
Net income attributable to the company
2.49%-7.26M
-7.10%-6.89M
-11.75%-27.75M
53.83%-3.95M
-125.16%-9.93M
-46.05%-7.44M
5.04%-6.44M
5.58%-24.84M
-10.36%-8.55M
9.53%-4.41M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
2.49%-7.26M
-7.10%-6.89M
-11.75%-27.75M
53.83%-3.95M
-125.16%-9.93M
-46.05%-7.44M
5.04%-6.44M
5.58%-24.84M
-10.36%-8.55M
9.53%-4.41M
Diluted earnings per share
16.67%-0.1
10.00%-0.09
4.65%-0.41
66.67%-0.05
-75.00%-0.14
-33.33%-0.12
16.67%-0.1
12.24%-0.43
-7.14%-0.15
11.11%-0.08
Basic earnings per share
16.67%-0.1
10.00%-0.09
4.65%-0.41
66.67%-0.05
-75.00%-0.14
-33.33%-0.12
16.67%-0.1
12.24%-0.43
-7.14%-0.15
11.11%-0.08
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 10.61%7.92M29.58%8.73M25.51%33.79M4.01%8.85M82.31%11.05M18.43%7.16M6.72%6.73M2.63%26.92M14.13%8.51M-1.54%6.06M
Selling and administrative expenses -2.80%3.36M-6.64%2.98M41.25%15.68M14.49%4.08M124.68%5.13M26.06%3.46M22.79%3.2M-13.71%11.1M7.32%3.57M-20.56%2.29M
-General and administrative expense -2.80%3.36M-6.64%2.98M41.25%15.68M14.49%4.08M124.68%5.13M26.06%3.46M22.79%3.2M-13.71%11.1M7.32%3.57M-20.56%2.29M
Research and development costs 23.16%4.56M62.28%5.74M14.76%17.71M-3.80%4.66M57.99%5.81M15.51%3.7M-4.56%3.54M19.44%15.43M31.61%4.84M12.18%3.68M
Depreciation amortization depletion --------2.81%403K8.08%107K6.19%103K---------13.27%392K--99K--97K
-Depreciation and amortization --------2.81%403K8.08%107K6.19%103K---------13.27%392K--99K--97K
Operating profit -10.61%-7.92M-29.58%-8.73M-25.51%-33.79M-4.01%-8.85M-82.31%-11.05M-18.43%-7.16M-6.72%-6.73M-2.63%-26.92M-14.13%-8.51M1.54%-6.06M
Net non-operating interest income (expenses) 27.34%340K68.30%446K151.14%1.33M55.73%489K108.90%305K444.90%267K1,372.22%265K433.33%528K1,292.89%314K467.21%146K
Non-operating interest income 27.34%340K68.30%446K151.14%1.33M55.73%489K108.90%305K444.90%267K1,372.22%265K433.33%528K1,292.89%314K467.21%146K
Other net income (expenses) 183.63%419K4,231.25%1.39M192.40%4.81M1,569.97%4.45M-45.29%825K-154.05%-501K106.57%32K1,482.35%1.65M-9.48%-303K19.28%1.51M
Gain on sale of security 183.63%419K4,231.25%1.39M192.40%4.81M1,569.97%4.45M-45.29%825K-154.05%-501K106.57%32K1,482.35%1.65M-9.48%-303K19.28%1.51M
Income before tax 3.15%-7.16M-7.10%-6.89M-11.73%-27.66M54.03%-3.91M-125.10%-9.92M-45.84%-7.39M5.04%-6.44M5.73%-24.75M-10.22%-8.5M9.43%-4.41M
Income tax 102.13%95K15.48%97K-24.56%43K250.00%7K88.00%47K71.43%84K36.20%57K-72.03%2K
Earnings from equity interest net of tax
Net income 2.49%-7.26M-7.10%-6.89M-11.75%-27.75M53.83%-3.95M-125.16%-9.93M-46.05%-7.44M5.04%-6.44M5.58%-24.84M-10.36%-8.55M9.53%-4.41M
Net income continuous operations 2.49%-7.26M-7.10%-6.89M-11.75%-27.75M53.83%-3.95M-125.16%-9.93M-46.05%-7.44M5.04%-6.44M5.58%-24.84M-10.36%-8.55M9.53%-4.41M
Noncontrolling interests
Net income attributable to the company 2.49%-7.26M-7.10%-6.89M-11.75%-27.75M53.83%-3.95M-125.16%-9.93M-46.05%-7.44M5.04%-6.44M5.58%-24.84M-10.36%-8.55M9.53%-4.41M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 2.49%-7.26M-7.10%-6.89M-11.75%-27.75M53.83%-3.95M-125.16%-9.93M-46.05%-7.44M5.04%-6.44M5.58%-24.84M-10.36%-8.55M9.53%-4.41M
Diluted earnings per share 16.67%-0.110.00%-0.094.65%-0.4166.67%-0.05-75.00%-0.14-33.33%-0.1216.67%-0.112.24%-0.43-7.14%-0.1511.11%-0.08
Basic earnings per share 16.67%-0.110.00%-0.094.65%-0.4166.67%-0.05-75.00%-0.14-33.33%-0.1216.67%-0.112.24%-0.43-7.14%-0.1511.11%-0.08
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data